Protection against vaginal SIV transmission with microencapsulated vaccine

Science. 1993 May 28;260(5112):1323-7. doi: 10.1126/science.8493576.

Abstract

Although protection in animal models against intravenous challenges with simian immunodeficiency virus (SIV) has been reported, no previous vaccines have protected against a heterosexual route of infection. In this study, five of six macaques were protected against vaginal challenge when immunized with formalin-treated SIV in biodegradable microspheres by the intramuscular plus oral or plus intratracheal route. Oral immunization alone did not protect. After a second vaginal challenge, three of four intramuscularly primed and mucosally boosted macaques remained protected. The data suggest that protection against human immunodeficiency virus vaginal transmission could be provided by microsphere-based booster vaccines when used to immunize women who are systemically primed.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Animals
  • Antibodies, Viral / analysis*
  • Antibodies, Viral / biosynthesis
  • Female
  • Immunization, Secondary
  • Injections, Intramuscular
  • Macaca mulatta
  • Mice
  • Microspheres
  • Simian Acquired Immunodeficiency Syndrome / immunology
  • Simian Acquired Immunodeficiency Syndrome / prevention & control*
  • Simian Acquired Immunodeficiency Syndrome / transmission
  • Simian Immunodeficiency Virus / immunology*
  • Trachea
  • Vaccination
  • Vagina / immunology*
  • Vagina / microbiology
  • Viral Vaccines* / administration & dosage

Substances

  • Antibodies, Viral
  • Viral Vaccines